WAI CHUN BIOTEC(00660): Possible delay in publishing full-year performance.
Weijun Biotechnology (00660) issued an announcement that the company's Chief Financial Officer will be on leave from September 14, 2024 due to family reasons.
WAI CHUN BIOTEC (00660) announces that the company's Chief Financial Officer has resigned from September 14, 2024 due to personal reasons, causing hindrances in providing information and documents to the auditors. As a result, the company needs additional time to finalize the audited financial results for the year ending June 30, 2024, and it may be delayed beyond the original announcement date of September 30, 2024.
The company is working closely with the auditors to provide all required information and documents to expedite the auditing process. However, the expected announcement date for the annual results will need to be further determined with the auditors and will be announced separately.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


